慢性鼻窦炎手术疗效评估中嗅觉功能的纵向改善与稳定性
本研究前瞻性纳入122例药物难治性慢性鼻窦炎成人患者,在内镜鼻窦手术后随访18个月,采用简易嗅觉识别测试(BSIT)评估嗅觉。术后6个月BSIT平均分改善(p=0.014),鼻息肉患者改善最明显(p=0.001);总体6至18个月无差异,但合并哮喘和鼻息肉者出现显著平均恶化。嗅觉异常患病率从术前28%降至6个月17%(p=0.015),12个月和18个月无显著变化。
要点
- 内镜鼻窦手术后6个月BSIT平均分改善(p=0.014),鼻息肉患者改善最明显(p=0.001)。
- 总体6至18个月BSIT平均分无差异,但合并哮喘(F(2)=5.29;p=0.010)和鼻息肉(F(2)=3.99;p=0.033)者报告显著平均恶化。
- 嗅觉异常患病率从术前28%降至6个月17%(p=0.015),12个月19%(p=0.791)和18个月21%(p=0.581)无显著变化。
核心结论
- 内镜鼻窦手术后6个月BSIT评分显示嗅觉改善,鼻息肉切除患者改善最明显。
- 多数患者亚组术后6至18个月总体改善持续,但合并哮喘和鼻息肉患者初始改善后嗅觉障碍加重,提示需进一步识别与慢性鼻窦炎嗅觉异常相关的预后因素。
研究设计与样本
- 前瞻性多机构队列研究,纳入药物难治性慢性鼻窦炎成人患者,内镜鼻窦手术后观察18个月。
- 共122例符合纳入标准的参与者,招募时间为2011年3月至2014年2月。
- 嗅觉采用BSIT评分在基线、术后6个月、12个月和18个月采集,使用重复测量方差分析(ANOVA)比较。
主要发现
- 所有参与者6个月随访时BSIT平均分改善(p=0.014),鼻息肉患者改善最明显(p=0.001)。
- 总体6个月与18个月之间BSIT平均分无差异。
- 合并哮喘(F(2)=5.29;p=0.010)和鼻息肉(F(2)=3.99;p=0.033)的受试者报告显著平均恶化。
- 所有受试者嗅觉异常患病率从术前28%降至6个月17%(p=0.015),12个月19%(p=0.791)和18个月21%(p=0.581)无显著变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abnormal olfaction is common with chronic rhinosinusitis (CRS) and associates with various measures of sinonasal inflammation. The Brief Smell Identification Test (BSIT) has demonstrated improvements in abnormal olfactory detection following endoscopic sinus surgery (ESS), but olfaction remains understudied using this instrument. Discerning longitudinal, postoperative durability in olfaction is critical for patient counseling. METHODS: Adult participants with medically recalcitrant CRS were prospectively enrolled into a multi-institutional cohort study and observed for 18 months after ESS. Olfaction was operationalized using BSIT scores collected at baseline, 6 months, 12 months, and 18 months postoperatively and compared using repeated measures analysis of variance (ANOVA). RESULTS: A total of 122 participants met inclusion criteria and were recruited between March 2011 and February 2014. Improvement in mean BSIT scores at 6-month follow-up were reported for all participants (p = 0.014) with greatest improvement in subjects with nasal polyposis (p = 0.001). No differences in mean BSIT scores were found between 6 months and 18 months overall; however, subjects with comorbid asthma (F(2) = 5.29; p = 0.010) and nasal polyposis (F(2) = 3.99; p = 0.033) reported significant mean worsening. Prevalence of abnormal olfaction decreased from 28% preoperatively to 17% at 6 months (p = 0.015), for all subjects, without significant change at 12 months (19%; p = 0.791) or at 18 months (21%; p = 0.581) postoperatively. CONCLUSION: Postoperative improvement in olfaction was reported 6 months after ESS using BSIT scores, with greatest improvements in patients undergoing polypectomy. Overall improvement persisted between 6 months and 18 months after ESS for most patient subgroups; however, dysosmia worsened after initial improvement in patients with asthma and nasal polyps, highlighting the need for further identification of prognostic factors associated with abnormal olfaction in CRS.
引用
- Levy JM, Mace JC, Sansoni ER, et al. Longitudinal improvement and stability of olfactory function in the evaluation of surgical management for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016. PMID: 27218483. doi:10.1002/alr.21800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。